Latent Autoimmune Diabetes in Adults (LADA)

被引:0
作者
Ramachandra G. Naik
Jerry P. Palmer
机构
[1] Bombay Hospital and Medical Research Center,
[2] University of Washington,undefined
来源
Reviews in Endocrine and Metabolic Disorders | 2003年 / 4卷
关键词
type 1 diabetes; type 2 diabetes; autoantibodies; late-onset type 1 diabetes; genetics; β-cell function;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:233 / 241
页数:8
相关论文
共 422 条
[51]  
Greulich B(1993)Insulin autoantibodies and high titre islet cell antibodies are preferentially associated with theHLADQA1*0301-DQB10302 haplotype at clinical type 1 (insulin-dependent) diabetes mellitus before age 10 years, but not at onset between age 10 and 40 years: The Belgian Diabetes Registry Diabetologia 36 1155-157
[52]  
Gries FA(1997)Distinct genetic and immunological features in patients with onset of IDDM before and after age 40 Diabetes Care 20 524-457
[53]  
Henrichs HR(1999)Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies Diabetes 48 150-616
[54]  
Betrams J(2003)Similar genetic features and different islet cell autoantibody pattern of Latent Autoimmune Diabetes in Adults (LADA) compared with adult-onset type 1 diabetes with rapid progression Diabetes Care 26 452-880
[55]  
Kolb H.(1999)Genetic heterogeneity of autoimmune diabetes: Age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43) Diabetologia 42 608-659
[56]  
Hagopian WA(1985)Increased reduction in fasting C-peptide is associated with islet cell antibodies in type 1 (insulin-dependent) diabetic patients Diabetologia 28 875-850
[57]  
Karlsen AE(1990)Persistence of antibodies to a 64,000-Mr islet cell protein after onset of type I diabetes Diabetes 39 653-80
[58]  
Gottsater A(1988)Predicting insulin-dependent diabetes Lancet i 845-1753
[59]  
Landin Olsson M(2000)Insulin and glucagon secretion in patients with slowly progressive autoimmune diabetes (LADA) J Clin Endocrinol Metab 85 76-935
[60]  
Grubin CE(2001)B-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): A randomized, double blind, phase II trial Lancet 358 1749-1277